Stevanato Group S.p.A. (STVN)
NYSE: STVN · IEX Real-Time Price · USD
28.23
+0.19 (0.68%)
May 1, 2024, 4:00 PM EDT - Market closed
Stevanato Group Employees
Stevanato Group had 5,634 employees on December 31, 2023. The number of employees increased by 374 or 7.11% compared to the previous year.
Employees
5,634
Change (1Y)
374
Growth (1Y)
7.11%
Revenue / Employee
$214,048
Profits / Employee
$28,721
Market Cap
8.58B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5,634 | 374 | 7.11% |
Dec 31, 2022 | 5,260 | 608 | 13.07% |
Dec 31, 2021 | 4,652 | 308 | 7.09% |
Dec 31, 2020 | 4,344 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Encompass Health | 37,761 |
Henry Schein | 25,000 |
Chemed | 15,087 |
Bio-Rad Laboratories | 8,030 |
Qiagen | 5,967 |
Legend Biotech | 1,826 |
Repligen | 1,783 |
Roivant Sciences | 904 |
STVN News
- 6 days ago - Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024 - Business Wire
- 5 weeks ago - Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters' Option to Purchase Additional Ordinary Shares - Business Wire
- 5 weeks ago - Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares - Business Wire
- 6 weeks ago - Stevanato Group Announces Public Offering of Ordinary Shares - Business Wire
- 7 weeks ago - Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum - Business Wire
- 7 weeks ago - Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023 - Business Wire
- 2 months ago - Stevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024 - Business Wire
- 3 months ago - Stevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and Commercialization - Business Wire